Ottobock Marks Successful IPO on Frankfurt Exchange

Ottobock, a leader in the MedTech arena, announced its successful initial public offering (IPO) on the Frankfurt Stock Exchange on October 9, 2025, with an opening trading price of EUR 72.00. This milestone marks a pivotal moment for the company as it steps into public ownership. The IPO is expected to support investments in future technologies, crucial for Ottobock's ongoing innovations in prosthetics and exoskeletons.

On the day of the IPO, around 200 employees and product users gathered at the Frankfurt Stock Exchange, celebrating this achievement with a live performance by British singer Sam Ryder. The IPO resulted in a market capitalization of about EUR 4.2 billion, with EUR 100 million raised through the issuance of new shares. Ottobock intends to allocate these proceeds toward advancing technology and expanding its global patient care network.